Certara stock.
Arena Pharmaceuticals. 22-Feb-1999. Later Stage VC. 0000. Completed. 5 buyers. To view Certara’s complete exits history, request access ». Information on stock, financials, earnings, subsidiaries, investors, and executives for Certara. Use the PitchBook Platform to explore the full profile.
Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ... Arsenal closed the previously announced $449M stock purchase from funds controlled by EQT Private EquityPRINCETON, N.J., Dec. 08, 2022 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT) today ...Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business.Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ...
A description of the common stock (the “Common Stock”) of Certara, Inc. (the “Registrant”) will be contained in a prospectus, constituting part of the Registrant’s Registration Statement on Form S-1 (File No. 333-250182) relating to the Common Stock, to be filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended (such prospectus as filed …Josh Xie is Director-Clinical Pharmacology at Certara, Inc. ... Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Stock markets for all 100% Free Registration. 100% Free RegistrationShare WA. Call · Chat WA · Facebook Twitter Youtube. Tanyakan tentang properti ini. Halo, saya tertarik dengan [RUMAH Cluster Certara Park Citra Raya – Cikupa].
Certara is the leading provider of mechanistic modeling software and consulting services, predicting outcomes for the global biopharm industry. The groundbreaking Simcyp Simulator is relied upon by pharmaceutical and biotech companies, academia and regulatory agencies, including the US FDA. Simcyp is committed to using technology and innovation ...
Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf. 0001959173-23-003878.rtf. View HTML: Aug 23, 2023: Statement of changes in beneficial ownership of securities. 4: 0001415889-23-012566.pdf. ... Please find the Certara ...Share WA. Call · Chat WA · Facebook Twitter Youtube. Tanyakan tentang properti ini. Halo, saya tertarik dengan [RUMAH Cluster Certara Park Citra Raya – Cikupa].Find real-time CERT - Certara Inc stock quotes, company profile, news and forecasts from CNN Business.Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued.
We would like to show you a description here but the site won’t allow us.
Discover historical prices for CERT stock on Yahoo Finance. View daily, weekly or monthly format back to when Certara, Inc. stock was issued. ... Certara, Inc. (CERT) NasdaqGS - NasdaqGS Real Time ...
Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ...The high in the last 52 weeks of Certara stock was 24.95. According to the current price, Certara is 58.68% away from the 52-week high. What are analysts …Dec 1, 2023 · The company had revenue of $85.58 million for the quarter, compared to analyst estimates of $85.96 million. Certara has generated ($0.21) earnings per share over the last year (($0.21) diluted earnings per share). Earnings for Certara are expected to decrease by -9.09% in the coming year, from $0.33 to $0.30 per share. Nov 21, 2023 · PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ... Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
While strong estimate revisions for Certara, Inc. have attracted decent investments and pushed the stock 13.2% higher over the past four weeks, further upside may still be left in the stock.1.37%. $3.03B. META | Complete Meta Platforms Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.The estimated Net Worth of William F Feehery is at least $78.7 Millón dollars as of 31 March 2023. Dr Feehery owns over 36,580 units of Certara stock worth over $45,530,211 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara.Contact Us U.S. markets open in 9 hours 29 minutes S&P Futures 4,574.25 -2.50(-0.05%) Dow Futures 36,033.00 +23.00(+0.06%) Nasdaq Futures 15,955.50 -30.00(-0.19%) …Nasdaq | CERT U.S.: Nasdaq Certara Inc. Watch list NEW Set a price target alert After Hours Last Updated: Nov 24, 2023 2:28 p.m. EST Delayed quote $ 15.20 0.23 1.54% After Hours Volume: 2.55K... Mar 17, 2023 · In terms of valuation, Certara Inc. stock appears to be trading at a premium compared to its peers in the same industry. The company's market capitalization stands at approximately $3.1 billion ...
Smart Screens. Smart Screens Search stocks using 100s of variables and make your own screensReiterates Full Year 2023 Financial GuidancePRINCETON, N.J., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today reported its financial results ...
With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ...Nov 28, 2023 · CERT Stock Overview. Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. About the company. CERT fundamental analysis. Snowflake Score. Valuation. 1 /6. Future Growth. Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Certara Inc have a median target of 19.00, with a high estimate of 21.00 and a low estimate of 16.00. The median estimate ...The estimated Net Worth of Leif E Pedersen is at least $6.21 Millón dollars as of 31 March 2023. Mr Pedersen owns over 8,646 units of Certara stock worth over $3,354,541 and over the last 2 years he sold CERT stock worth over $2,563,711. In addition, he makes $295,397 as Pres of Software at Certara.William Blair Investment Management LLC grew its position in shares of Certara, Inc. (NASDAQ:CERT - Free Report) by 4.4% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 7,026,786 shares of the company's sCertara Inc Ordinary Shares 700 Morningstar Rating Unlock Stock XBER Rating as of Nov 24, 2023 Summary Chart News Price vs Fair Value Sustainability …
Certara Inc. stock grades by Barron's. ... Stock Movers: Gainers, decliners and most actives market activity tables are a combination of NYSE, Nasdaq, NYSE American and NYSE Arca listings.
Nov 8, 2023 · Certara, Inc. (CERT) delivered earnings and revenue surprises of 0% and 0.45%, respectively, for the quarter ended September 2023. Do the numbers hold clues to what lies ahead for the stock?
The estimated Net Worth of Richard M. Traynor is at least $8.32 Million dollars as of 11 May 2023. Mr Traynor owns over 5,000 units of Certara stock worth over $2,497,341 and over the last 3 years he sold CERT stock worth over $5,825,760.The high quality of our work is the result of dedication, collaboration, and deep expertise. By choosing to partner with Certara, you tap into the expertise and insights of more than 1,100 leading drug development, regulatory science, and market access solutions’ experts who are committed to finding the right answers and increasing the probability of your success.Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing. 144: 0001959173-23-003878.pdf. 0001959173-23-003878.rtf. View HTML: Aug 23, 2023: Statement of changes in beneficial ownership of securities. 4: 0001415889-23-012566.pdf. ... Please find the Certara ...PRINCETON, N.J.—November 22, 2021– Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the closing of its underwritten public offering of 10,000,000 shares of its common stock by certain existing stockholders at a public offering price of $31.00 per share.Certara Inc. (NASDAQ:NASDAQ:CERT) Q3 2023 Earnings Conference Call November 8, 2023 5:00 PM ETCompany ParticipantsDavid Deuchler - Investor Relations...According to 7 stock analysts, the average 12-month stock price forecast for Certara stock is $50.29, which predicts an increase of 240.60%. The lowest target is $16 and the highest is $235. On average, analysts rate Certara stock as a buy.Investors in Certara, Inc. CERT need to pay close attention to the stock based on moves in the options market lately. That is because the Nov 17, 2023 $12.50 Call had some of the highest implied ...The estimated net worth of Robert Aspbury is at least $5.51 million as of June 14th, 2021. Dr. Aspbury owns 375,451 shares of Certara stock worth more than $5,511,621 as of November 28th. This net worth estimate does not reflect any other investments that Dr. Aspbury may own.
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.Dr Feehery owns over 36,580 units of Certara stock worth over $42,522,670 and over the last 11 years he sold CERT stock worth over $31,782,752. In addition, he makes $1,387,564 as CEO & Director at Certara. Wallmine is a …According to the issued ratings of 8 analysts in the last year, the consensus rating for Certara stock is Hold based on the current 5 hold ratings and 3 buy ratings for CERT. The average twelve-month price prediction for Certara is $19.71 with a high price target of $24.00 and a low price target of $16.00. Learn more on CERT's analyst rating ...PRINCETON, N.J., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced the introduction of Simcyp™ Biopharmaceutics software. It is ...Instagram:https://instagram. li cycle corptoyota sotckwhere do i buy penny stocksbest stock scanners Oct 17, 2023 · With Certara, Inc. shares trading a bit north of 30 times earnings and nearly 6.5 times forward sales, there is nothing compelling about the stock's current valuation given Certara's projected ... silver price forcasttiaa cref money market rates Craig Rayner CERT stock SEC Form 4 insiders trading. Craig has made over 2 trades of the Certara stock since 2021, according to the Form 4 filled with the SEC. Most recently Craig sold 54,462 units of CERT stock worth $1,978,604 on 2 September 2021.. The largest trade Craig's ever made was selling 108,924 units of Certara stock on 11 …Certara, Inc. : Trading strategies, financial analysis, commentaries and investment guidance for Certara, Inc. Stock | Mexican Stock Exchange: CERT ... ria registered investment advisor At closing, equity holders of Pinnacle 21 received approximately $250 million in cash consideration and 2,239,717 shares of Certara restricted common stock, subject to certain customary closing adjustments. The transaction is expected to be accretive to Certara’s revenue, revenue growth, and adjusted EBITDA.Certara Price Performance. CERT stock opened at $14.64 on Friday. The company has a quick ratio of 3.51, a current ratio of 3.51 and a debt-to-equity ratio of 0.27. The business has a 50 day ...